Estate Counselors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-127,720
Closed -$9.33M 141
2023
Q3
$9.33M Buy
127,720
+4,835
+4% +$386K 1.24% 25
2023
Q2
$10.2M Sell
122,885
-87,505
-42% -$7.32M 1.3% 25
2023
Q1
$16M Buy
210,390
+132,175
+169% +$11M 2.12% 19
2022
Q4
$6.49M Buy
78,215
+4,130
+6% +$334K 0.91% 34
2022
Q3
$5.88M Sell
74,085
-84,255
-53% -$7.1M 0.91% 30
2022
Q2
$11.8M Buy
+158,340
New +$11.9M 1.75% 17

Other funds holding XBI

Estate Counselors's XBI Position: Q4 2023 in Review

Estate Counselors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2023, closing a stake of 127,720 shares — an estimated $9.33M sold.

Estate Counselors first reported a position in XBI in Q2 2022 and held it in 6 quarters. The position peaked at $16M in Q1 2023. 745 funds tracked by Wall St. Rank hold XBI as of Q4 2023.

  • Estate Counselors reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2023 after selling out during the quarter.
  • Estate Counselors sold 127,720 State Street SPDR S&P Biotech ETF shares in Q4 2023, an estimated $9.33M.
  • Estate Counselors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and held it in 6 quarters.
  • Estate Counselors's State Street SPDR S&P Biotech ETF position peaked at $16M in Q1 2023.
  • 745 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2023.

Based on Estate Counselors's 13F filing for Q4 2023, filed 23 Jan 2024.